|
Status |
Public on Jun 29, 2022 |
Title |
Glucose supply and glycolysis inhibition shape the clinical fate of preterm newborns infected with Staphylococcus epidermidis |
Organism |
Sus scrofa |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
35503431 |
Submission date |
Apr 26, 2022 |
Last update date |
Jun 30, 2022 |
Contact name |
tik muk |
E-mail(s) |
tik.muk@sund.ku.dk
|
Phone |
52708180
|
Organization name |
University of Copenhagen
|
Street address |
Dyrlægevej 68,1870 Frederiksberg C, Dyrlægevej 68, 1870 Frederiksberg C
|
City |
Copenhagen |
State/province |
copenhagen |
ZIP/Postal code |
1870 |
Country |
Denmark |
|
|
Platforms (1) |
GPL26351 |
Illumina NovaSeq 6000 (Sus scrofa) |
|
Samples (96)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE201539 |
Glucose supply and glycolysis inhibition shape the clinical fate of preterm newborns infected with Staphylococcus epidermidis [cord blood] |
GSE201550 |
Glucose supply and glycolysis inhibition shape the clinical fate of preterm newborns infected with Staphylococcus epidermidis [liver] |
GSE201552 |
Glucose supply and glycolysis inhibition shape the clinical fate of preterm newborns infected with Staphylococcus epidermidis [whole blood] |
|
Relations |
BioProject |
PRJNA832210 |